NCT04108481 2025-03-28
iRE-C
University of Iowa
Phase 1 Terminated
Clinical Trials
5 trialsNCT04083365 2023-05-31
PANDORA
AUSL Romagna Rimini
Phase 2 Unknown
NCT03102047 2022-04-20
Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer
NSABP Foundation Inc
Phase 2 Completed
NCT04293419 2021-06-21
DUREC
Grupo Espanol Multidisciplinario del Cancer Digestivo
Phase 2 Unknown
NCT04621370 2020-11-09
PRIME-RT
Cancer Research UK, Glasgow
Phase 2 Unknown